AX20017 is primarily utilized in the field of biomedical research, particularly in the development of therapeutic agents. It has shown potential in targeting specific cellular pathways, making it a candidate for the treatment of various diseases, including cancer. Researchers are exploring its efficacy in inhibiting abnormal cell growth and enhancing the effectiveness of existing treatments. Additionally, it is being studied for its role in modulating immune responses, which could lead to advancements in immunotherapy. Its application extends to preclinical studies, where it is used to understand disease mechanisms and evaluate potential drug candidates.